BioNexus Gene Lab Corp. has completed an IPO in the amount of $5 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 1,250,000
PriceRange: $4
Discount Per Security: $0.32
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5899 USD | +1.20% | -0.02% | +11.30% |
Apr. 16 | BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 29 | BioNexus Gene Lab Corp. Provides Information to Shareholders | CI |
1st Jan change | Capi. | |
---|---|---|
+11.30% | 10.3M | |
+29.71% | 49.18B | |
+0.73% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.67% | 26.09B | |
-22.83% | 18.71B | |
+8.11% | 13.26B | |
+32.42% | 12.32B | |
-0.67% | 11.99B |